Skip to main content
. 2012 Dec 13;5:49–64. doi: 10.4137/IJTR.S10627

Figure 4.

Figure 4

Kynurenine aminotransferase II (KAT II) in the frontal cortex and cerebellum of different pathological subgroups of patients after HIV-1 infection.

Notes: Values represent the mean ± SEM of following groups: Control (CO, n = 16); Pathological subgroups: HIV in brain tissue by immunocytochemistry (HIV, n = 6); opportunistic infection (OPP, n = 15); malignant lymphoma (LY, n = 5); infarction of brain (INF, n = 5) and glial dystrophy (GD, n = 5). Significance: **P < 0.01; ***P < 0.001 compared with control Statistical analysis for frontal cortex: c, e indicates statistical significance at P < 0.05; b, d indicates statistical significance at P < 0.02; a, d indicates statistical significance at P < 0.01; d, e indicates statistical significance at P < 0.003; a, c indicates statistical significance at P < 0.001, analysis of variance: F = 4.366, P = 0.002. Statistical analysis for cerebellum; one-way analysis of variance, F = 0.3238, P = 0.8960.